News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News ACC 2023 TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR Todd Neale March 04, 2023
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News ACC 2021 Wide Variation in TAVI Readmission Rates Among US Hospitals L.A. McKeown May 07, 2021
News Conference News ACC 2018 Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint Caitlin E. Cox March 19, 2018
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 Study Looks at Long-term Mortality Predictors in TAVR Patients Jason Kahn March 27, 2012